NYMOX PHARMACEUTICAL CORPORATION Current Liabilities
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Current Liabilities of $7.43 million as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2025-06-03
- 2024-12-31: Current Liabilities $7.43M.
- 2024-09-30: Current Liabilities $6.92M.
- 2023-12-31: Current Liabilities $3.80M.
- 2023-09-30: Current Liabilities $2.57M.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2024-12-31 | $7.43M 20-F · filed 2025-06-03 | |
| 2024-09-30 | $6.92M 6-K · filed 2025-01-02 | |
| 2023-12-31 | $3.80M 20-F · filed 2025-06-03 | |
| 2023-09-30 | $2.57M 6-K · filed 2023-11-15 | |
| 2023-06-30 | $3.15M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $2.37M 6-K · filed 2023-05-12 | |
| 2022-12-31 | $2.11M 20-F · filed 2024-08-29 | |
| 2022-09-30 | $2.36M 6-K/A · filed 2022-11-16 | |
| 2022-06-30 | $2.19M 6-K · filed 2022-08-15 | |
| 2022-03-31 | $2.52M 6-K · filed 2022-05-13 | |
| 2021-12-31 | $1.79M 20-F · filed 2023-05-02 | |
| 2021-09-30 | $1.82M 6-K · filed 2021-11-12 | |
| 2021-06-30 | $1.66M 6-K · filed 2021-08-13 | |
| 2021-03-31 | $1.13M 6-K · filed 2021-05-14 | |
| 2020-12-31 | $1.97M 20-F · filed 2022-03-30 | $1.83M 20-F · filed 2021-03-29 |
| 2020-09-30 | $1.90M 6-K · filed 2020-11-13 | |
| 2020-06-30 | $2.02M 6-K · filed 2020-08-14 | |
| 2020-03-31 | $1.81M 6-K · filed 2020-05-14 | |
| 2019-12-31 | $2.04M 20-F · filed 2022-03-30 | |
| 2019-09-30 | $1.66M 6-K · filed 2019-11-13 | |
| 2019-06-30 | $1.71M 6-K · filed 2019-08-14 | |
| 2019-03-31 | $1.43M 6-K · filed 2019-05-15 | |
| 2018-12-31 | $1.07M 20-F · filed 2021-03-29 | |
| 2017-12-31 | $2.23M 20-F · filed 2020-03-30 |